Clinical Trial: MEDI5752 in Japanese Patients With Advanced Solid Tumors.
Study Status: COMPLETED
Recruit Status: COMPLETED
Condition: Advanced Solid Tumors
Study Type: INTERVENTIONAL
Official Title: A Phase 1, Open-label Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Immunogenicity, and Antitumor Activity of MEDI5752 in Japanese Subjects With Advanced Solid Tumors
Brief Summary:
This is a Phase 1, open-label study evaluate the safety, tolerability, pharmacokinetics, immunogenicity and anti-tumor activity of MEDI5752 in Japanese patients with advanced solid solid tumors.
Read more